Volume 58, Issue 11 p. 1396-1405
Editor's Choice: Review

The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava

C. Michael White PharmD, FCP, FCCP

Corresponding Author

C. Michael White PharmD, FCP, FCCP

Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Director, Health Outcomes, Policy, and Evidence Synthesis (HOPES) Research Group, UConn and Hartford Hospital, Hartford, CT, USA

Corresponding Author:

C. Michael White, PharmD, FCP, FCCP, Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Director, Health Outcomes, Policy, and Evidence Synthesis (HOPES) Research Group, UConn and Hartford Hospital, 80 Seymour Street, Hartford, CT 06102-5037

Email: [email protected]

Search for more papers by this author
First published: 23 May 2018
Citations: 21

Abstract

Kava is a plant with numerous kavapyrones that can induce pharmacologic effects and drug interactions through the cytochrome P450 and P-glycoprotein systems. Kava is used recreationally and for the treatment of anxiety. Clinical trials verify anxiolytic effects in excess of placebo, but the effects are not seen immediately and the optimal dose and dosing schedule needs to be determined. Clinical trials usually lasting for 4 weeks found generally good tolerability and safety; however, dermatologic, hepatologic, and cognitive adverse effects may occur. Some of these adverse effects are known to occur from the kavapyrones themselves, while others can be caused or exacerbated by use of substandard kava products. There is tremendous variability in the constitution of a kava product based on the parts of the plant that are being extracted and the extraction method. The most commonly studied extract for the treatment of anxiety is the acetone extract.